This raises the hypothesis that suppression on the level of TGF-β in CRC may, on one hand, inhibit its own signal pathway, and on the other hand, polarize the TANs to an anti-tumor phenotype, which ultimately attenuates tumor growth. This evidence concerns the gene TGFB1 and neoplasm.